Your browser doesn't support javascript.
loading
Prevalence, Safety and Long-Term Retention Rates of Biologics in Hong Kong from 2001 to 2015.
Ge, Mengqin; Man, Kenneth K; Chui, Celine S; Chan, Esther W; Wong, Ian C; Li, Xue.
Afiliação
  • Ge M; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 2/F, 21 Sassoon Road, Laboratory Block, Hong Kong, China.
  • Man KK; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 2/F, 21 Sassoon Road, Laboratory Block, Hong Kong, China.
  • Chui CS; Research Department of Practice and Policy, UCL School of Pharmacy, London, UK.
  • Chan EW; Department of Medical Informatics, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Wong IC; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 2/F, 21 Sassoon Road, Laboratory Block, Hong Kong, China.
  • Li X; WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Drug Saf ; 42(9): 1091-1102, 2019 09.
Article em En | MEDLINE | ID: mdl-31168709

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Padrões de Prática Médica / Antirreumáticos / Infliximab Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Drug Saf Assunto da revista: TERAPIA POR MEDICAMENTOS / TOXICOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Nova Zelândia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Padrões de Prática Médica / Antirreumáticos / Infliximab Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Drug Saf Assunto da revista: TERAPIA POR MEDICAMENTOS / TOXICOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Nova Zelândia